Clinical Trial: An open-label, single-arm, prospective study of adebrelimab in combination with concurrent chemoradiotherapy for elderly patients with biliary tract cancer (China)

Posted On: 2026-08-24

China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An open-label, single-arm, prospective study of adebrelimab in combination with concurrent chemoradiotherapy for elderly patients with biliary tract cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130636

Registration Time: 2026/08/22

Type: Interventional study

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337700

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: An open-label, single-arm, prospective study of adebrelimab in combination with concurrent chemoradiotherapy for elderly patients with biliary tract cancer (China)